Phase II multicenter study of iodine-131 anti-B1 antibody consolidation for patients with diffuse large B-cell non-Hodgkin's lymphoma following first-line CHOP
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2013
At a glance
- Drugs Iodine-131 tositumomab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 11 Jun 2013 The recruitment status is unknown, not recently verified, according to ClinicalTrials.gov.
- 25 Sep 2005 New trial record.